Innovation

Healthcare

A new study in JAMA found that clear face masks enhanced communication and trust between medical providers and patients.

The continent’s suspensions are eroding vaccine confidence just when the world needs it the most.

Oxycontin-maker Purdue Pharma submitted its bankruptcy restructuring plan late on Monday night.

Biotech company Moderna announced today that it has given the first doses of its mRNA Covid-19 vaccine to young children as part of a new study to test how effective the vaccine is in kids.

The new candidate uses a mechanism to prompt immune responses that is different from vaccines already in circulation, but remains effective against non-variant forms of the virus.

The work of changing healthcare is too often fraught with flawed decision-making processes, pilot-obsession, and incrementalism. I propose some ways out.

A new Covid-19 therapy has completed its phase two human trial and the results are promising. Molnupiravir, developed by Ridgeback Biotherapeutics LP and Merck & Co., reached its endpoint objective of reducing the length of Covid-19 infections, according to a Merck press release.

The dangers of relaxing Covid-19 restrictions are apparent in the rising numbers of new infections across Europe.

It is true that the CARES Act’s Provider Relief Fund did help hospitals all across the country stay afloat. However, as earnings reports reveal, not all hospitals and health systems are financially struggling nearly as badly as people thought they would.

The strain of healthcare costs has gotten worse for everyone during Covid-19, even people with good credit, according to a report from the Center for the New Middle Class.

Lyft said Hilton and Delta Airlines will join the ride-sharing giant’s effort to mobilize 60 million low-income Americans to Covid-19 vaccination sites across the U.S.

Up to 40% of Covid-19 survivors have long-lasting neuropsychiatric symptoms, and scientists and clinicians are preparing for the influx of neuropsychiatric patients.

AstraZeneca, international regulators, and numerous experts all say the vaccine is safe and there is no evidence it is linked to blood clots.

The clinical trials are being planned carefully due to ethical implications of testing vaccines in young children.

Multiple experts say that the drug company’s vaccine is being unfairly targeted by EU countries, hindering plans to roll it out worldwide at a critical time.

Italy has been among the hardest hit countries during the pandemic.

The B.1.1.7 variant is already known to be more transmissible, but according to new research, it is associated with 55% higher mortality too.